MicroRNA expression profiles in familial hypertrophic cardiomyopathy with myosin-binding protein C3 (MYBPC3) gene mutations

MicroRNA expression profiles in familial hypertrophic cardiomyopathy with myosin-binding protein C3 (MYBPC3) gene mutations

Abstract Familial hypertrophic cardiomyopathy (FHCM) is an autosomal dominant inherited disease caused by mutations in genes encoding cardiac sarcomere proteins. MicroRNAs (miRNAs) play an important role in the pathogenesis of FHCM. In the present study, we aimed to determine the miRNA profile in FH...

Full description

Bibliographic Details
Main Authors:	Li-rong Lin, Xue-qun Hu, Li-hong Lu, Jia-zhen Dai, Ning-ning Lin, Re-hua Wang, Zhang-xin Xie, Xue-mei Chen
Format:	Article
Language:	English
Published:	BMC 2022-06-01
Series:	BMC Cardiovascular Disorders
Subjects:	Familial hypertrophic cardiomyopathy MYBPC3 Gene mutation MicroRNA-sequencing
Online Access:	https://doi.org/10.1186/s12872-022-02714-6

Similar Items

An Update on MYBPC3 Gene Mutation in Hypertrophic Cardiomyopathy
by: Bogdan-Sorin Tudurachi, et al.
Published: (2023-06-01)

Familial hypertrophic cardiomyopathy: A case with a new mutation in the MYBPC3 gene
by: Olgu Hallioglu Kilinc, et al.
Published: (2017-07-01)

A human <it>MYBPC3</it> mutation appearing about 10 centuries ago results in a hypertrophic cardiomyopathy with delayed onset, moderate evolution but with a risk of sudden death
by: Teirlinck Carolien H, et al.
Published: (2012-11-01)

MYBPC3Δ25bp intronic deletion in hypertrophic cardiomyopathy patients and healthy Iranian population
by: Leila Emrahi, et al.
Published: (2021-04-01)

Untargeted Metabolomics Identifies Potential Hypertrophic Cardiomyopathy Biomarkers in Carriers of <i>MYBPC3</i> Founder Variants
by: Mark Jansen, et al.
Published: (2023-02-01)

A pathogenic nonsense mutation (c.1522C>T) of the MYBPC3 gene is implicated with hypertrophic cardiomyopathy
by: Erru Ni, et al.
Published: (2023-08-01)

Repair of Mybpc3 mRNA by 5′-trans-splicing in a Mouse Model of Hypertrophic Cardiomyopathy
by: Giulia Mearini, et al.
Published: (2013-01-01)

Pathogenic Intronic Splice-Affecting Variants in <i>MYBPC3</i> in Three Patients with Hypertrophic Cardiomyopathy
by: Katherine A. Wood, et al.
Published: (2021-06-01)

Heterogeneous Distribution of Genetic Mutations in Myosin Binding Protein-C Paralogs
by: Darshini A. Desai, et al.
Published: (2022-06-01)

Generation of two iPSC lines from hypertrophic cardiomyopathy patients carrying MYBPC3 and PRKAG2 variants
by: Amit Manhas, et al.
Published: (2022-05-01)

Description of a Cohort with a New Truncating <i>MYBPC3</i> Variant for Hypertrophic Cardiomyopathy in Northern Spain
by: Natalia Fernández Suárez, et al.
Published: (2023-03-01)

A novel Loss-of-function Mutation in MYBPC3 Causes familial hypertrophic cardiomyopathy with extreme intrafamilial phenotypic heterogeneity
by: Peng Y, et al.
Published: (2023-03-01)

Mixed Hypertrophic and Dilated Phenotype of Cardiomyopathy in a Patient With Homozygous In-Frame Deletion in the MyBPC3 Gene Treated as Myocarditis for a Long Time
by: Olga Blagova, et al.
Published: (2020-09-01)

Identification of Two Homozygous Variants in <i>MYBPC3</i> and <i>SMYD1</i> Genes Associated with Severe Infantile Cardiomyopathy
by: Marta W. Szulik, et al.
Published: (2023-03-01)

Novel MYBPC3 Mutations in Indian Population with Cardiomyopathies
by: Rani DS, et al.
Published: (2023-09-01)

Transcriptome Profile Identifies Actin as an Essential Regulator of Cardiac Myosin Binding Protein C3 Hypertrophic Cardiomyopathy in a Zebrafish Model
by: Sahar Isa Da’as, et al.
Published: (2022-08-01)

Myocardial Deformation Analysis in <i>MYBPC3</i> and <i>MYH7</i> Related Sarcomeric Hypertrophic Cardiomyopathy—The Graz Hypertrophic Cardiomyopathy Registry
by: Viktoria Höller, et al.
Published: (2021-09-01)

Different Phenotypes of Sarcomeric <i>MyBPC3</i>-Cardiomyopathy in the Same Family: Hypertrophic, Left Ventricular Noncompaction and Restrictive Phenotypes (in Association with Sarcoidosis)
by: Olga Blagova, et al.
Published: (2022-07-01)

Combined PTPN11 and MYBPC3 Gene Mutations in an Adult Patient with Noonan Syndrome and Hypertrophic Cardiomyopathy
by: Martina Caiazza, et al.
Published: (2020-08-01)

Assessment of the Contribution of a Thermodynamic and Mechanical Destabilization of Myosin-Binding Protein C Domain C2 to the Pathomechanism of Hypertrophic Cardiomyopathy-Causing Double Mutation <i>MYBPC3</i><sup>Δ<i>25bp/D389V</i></sup>
by: Frederic V. Schwäbe, et al.
Published: (2021-11-01)

Phenotypic Diversity of Cardiomyopathy Caused by an <i>MYBPC3</i> Frameshift Mutation in a Korean Family: A Case Report
by: Joonhong Park, et al.
Published: (2021-03-01)

Nebivolol Desensitizes Myofilaments of a Hypertrophic Cardiomyopathy Mouse Model
by: Sabrina Stücker, et al.
Published: (2017-08-01)

Mutations in <i>MYBPC3</i> and <i>MYH7</i> in Association with Brugada Type 1 ECG Pattern: Overlap between Brugada Syndrome and Hypertrophic Cardiomyopathy?
by: Marianna Farnè, et al.
Published: (2021-09-01)

Genetic Study of Hypertrophic Cardiomyopathy in Iranian children: The Role of a De novo Variant
by: Arastoo Kaki, et al.
Published: (2023-09-01)

The combination of left ventricular non-compaction and hypertrophic cardiomyopathy in one family with a pathogenic variant in the MYBPC3 gene (rs397516037)
by: R. P. Myasnikov, et al.
Published: (2020-11-01)

Experience in genetic testing of hypertrophic cardiomyopathy using nanopore DNA sequencing
by: R. R. Salakhov, et al.
Published: (2021-11-01)

Proteasome inhibition slightly improves cardiac function in mice with hypertrophic cardiomyopathy
by: Saskia eSchlossarek, et al.
Published: (2014-12-01)

MicroRNAs in Hypertrophic, Arrhythmogenic and Dilated Cardiomyopathy
by: Enrica Chiti, et al.
Published: (2021-09-01)

The levels of certain circulating microRNAs in hypertrophic cardiomyopathy are associated with echocardiographic parameters
by: Maria V. Pisklova, et al.
Published: (2023-05-01)

Genetic determinants of clinical phenotype in hypertrophic cardiomyopathy
by: Lazar Velicki, et al.
Published: (2020-12-01)

ALU transposition induces familial hypertrophic cardiomyopathy
by: Landry Nfonsam, et al.
Published: (2020-01-01)

Investigation of Mutations in Exons 15 and 18 of MYBPC3 Gene in Hypertrophic Cardiomyopathy Patients
by: Behnaz Sadat Abedi, et al.
Published: (2015-08-01)

Western diet triggers cardiac dysfunction in heterozygous Mybpc3-targeted knock-in mice: A two-hit model of hypertrophic cardiomyopathy
by: Edgar E. Nollet, et al.
Published: (2023-12-01)

Prevalence and Phenotypic Expression of Mutations in the MYH7, MYBPC3 and TNNT2 Genes in Families with Hypertrophic Cardiomyopathy in the South of Brazil: A Cross-Sectional Study
by: Beatriz Piva e Mattos, et al.

Mutation in the beta-myosin heavy chain (β-MHC) gene of adult Bangladeshi patients with hypertrophic cardiomyopathy
by: Laila Anjuman Banu, et al.
Published: (2023-02-01)

Mutation in the beta-myosin heavy chain (β-MHC) gene of adult Bangladeshi patients with hypertrophic cardiomyopathy
by: Laila Anjuman Banu, et al.
Published: (2023-02-01)

Mutation in the beta-myosin heavy chain (β-MHC) gene of adult Bangladeshi patients with hypertrophic cardiomyopathy
by: Laila Anjuman Banu, et al.
Published: (2023-02-01)

A Novel Homozygous Intronic Variant in TNNT2 Associates With Feline Cardiomyopathy
by: James W. McNamara, et al.
Published: (2020-11-01)

Evaluation of MYBPC3 trans-Splicing and Gene Replacement as Therapeutic Options in Human iPSC-Derived Cardiomyocytes
by: Maksymilian Prondzynski, et al.
Published: (2017-06-01)

Severe apical hypertrophic cardiomyopathy with Ser 236 Gly mutation in MYBPC3: A three-year follow-up investigation
by: XueJiang Cen, et al.
Published: (2017-09-01)